The EMA’s Committee for Medicinal Products for Human Use (CHMP) determined that expected clinical benefits of seladelpar include delayed development of liver fibrosis and cirrhosis, potentially ...
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor that regulates intestinal inflammation. PPARγ is highly expressed in the colon and can be activated by various dietary ...
Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.
There are numerous trials revealing a blood pressure-lowering effect of thiazolidinediones in diabetic patients as well as in non-diabetic patients. Most of these studies are well designed but ...
but also by cautionary tales from past efforts to borrow from the diabetes armamentarium for asthma," like thiazolidinediones and peroxisome proliferator-activated receptor γ agonists ...